Literature DB >> 17097694

The odour span task: a novel paradigm for assessing working memory in mice.

Jared W Young1, Lorraine E Kerr, John S Kelly, Hugh M Marston, Christopher Spratt, Keith Finlayson, John Sharkey.   

Abstract

Impoverished odour recognition and memory are amongst the earliest symptoms observed in mild cognitive impairment, Alzheimer's disease and schizophrenia, and have been advocated as early disease bio-markers. Although transgenic animals modelling disease pathologies continually emerge, there remains a paucity of tasks to examine olfactory working memory in mice. The present studies describe a mouse odour span task, which assesses the ability to remember increasing numbers of odours. Since caspase-3 is highly expressed throughout the olfactory system, we postulated that mice over-expressing this apoptogenic protein would exhibit impaired performance in the odour span task. Mice over-expressing human caspase-3 (Tg) exhibited age-independent deficits in olfactory working memory (6-18 months) compared with wild-type littermates, requiring longer for task acquisition and exhibiting impaired asymptotic performance, with reduced span lengths, lower accuracy and increased error rates. These impairments appeared to be selective for working memory, as Tg mice had no deficits in odour discriminatory ability or in locomotor measures. Importantly, nicotine, which improves working memory span in man, reversed the deficits exhibited by Tg mice. In conclusion, the mouse odour span task can detect subtle changes in olfactory working memory induced by genetic manipulation and drug administration and therefore should be applied to animal models of neurological disease.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17097694     DOI: 10.1016/j.neuropharm.2006.09.006

Source DB:  PubMed          Journal:  Neuropharmacology        ISSN: 0028-3908            Impact factor:   5.250


  30 in total

1.  Nicotine improves working memory span capacity in rats following sub-chronic ketamine exposure.

Authors:  Samantha L Rushforth; Thomas Steckler; Mohammed Shoaib
Journal:  Neuropsychopharmacology       Date:  2011-09-28       Impact factor: 7.853

Review 2.  Mouse models for studying genetic influences on factors determining smoking cessation success in humans.

Authors:  F Scott Hall; Athina Markou; Edward D Levin; George R Uhl
Journal:  Ann N Y Acad Sci       Date:  2012-02       Impact factor: 5.691

3.  Effects of dizocilpine (MK801) on olfactory span in rats.

Authors:  Dave A MacQueen; Laura Bullard; Mark Galizio
Journal:  Neurobiol Learn Mem       Date:  2010-11-11       Impact factor: 2.877

Review 4.  Investigating the underlying mechanisms of aberrant behaviors in bipolar disorder from patients to models: Rodent and human studies.

Authors:  Jordy van Enkhuizen; Mark A Geyer; Arpi Minassian; William Perry; Brook L Henry; Jared W Young
Journal:  Neurosci Biobehav Rev       Date:  2015-08-19       Impact factor: 8.989

5.  Validation of the human odor span task: effects of nicotine.

Authors:  David A MacQueen; David J Drobes
Journal:  Psychopharmacology (Berl)       Date:  2017-07-14       Impact factor: 4.530

6.  Delayed procedural learning in α7-nicotinic acetylcholine receptor knockout mice.

Authors:  J W Young; J M Meves; I S Tarantino; S Caldwell; M A Geyer
Journal:  Genes Brain Behav       Date:  2011-07-07       Impact factor: 3.449

7.  Behavioral pharmacology of the odor span task: Effects of flunitrazepam, ketamine, methamphetamine and methylphenidate.

Authors:  Mark Galizio; Brooke April; Melissa Deal; Andrew Hawkey; Danielle Panoz-Brown; Ashley Prichard; Katherine Bruce
Journal:  J Exp Anal Behav       Date:  2016-10-17       Impact factor: 2.468

8.  Olfactory Stimulus Control and the Behavioral Pharmacology of Remembering.

Authors:  Mark Galizio
Journal:  Behav Anal (Wash D C)       Date:  2016-03-17

9.  GBR 12909 administration as a mouse model of bipolar disorder mania: mimicking quantitative assessment of manic behavior.

Authors:  Jared W Young; Andrew K L Goey; Arpi Minassian; William Perry; Martin P Paulus; Mark A Geyer
Journal:  Psychopharmacology (Berl)       Date:  2009-12-18       Impact factor: 4.530

Review 10.  Using the MATRICS to guide development of a preclinical cognitive test battery for research in schizophrenia.

Authors:  Jared W Young; Susan B Powell; Victoria Risbrough; Hugh M Marston; Mark A Geyer
Journal:  Pharmacol Ther       Date:  2009-03-06       Impact factor: 12.310

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.